Pirenzepine

Pirenzepine - Wikipedia, the free encyclopedia
Pirenzepine (marketed by Boehringer Ingelheim under the trade-name Gastrozepin) is used in the treatment of peptic ulcers, as it reduces gastric acid ...

Pirenzepine. A review of its pharmacodynamic and pharmacokinetic ...
Pirenzepine is a 'selective' antimuscarinic agent which, unlike classic anticholinergic agents, inhibits gastric acid secretion at lower doses than are ...

File:Pirenzepine.png - Wikipedia, the free encyclopedia
File:Pirenzepine.png. Size of this preview: 390 × 600 pixels ... File: Pirenzepine.png Gtk-go-forward-ltr.svg File:Pirenzepin.svg ...

Pirenzepine affects scleral metabolic changes in myopia through a ...
Chicks were monocularly deprived (MD) of pattern vision and given daily intravitreal injections of either pirenzepine (700 microg) or saline vehicle into ...

Pirenzepine - PubChem Public Chemical Database
Pirenzepine - Substance Summary (SID 17398264) An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect ...

Short term pirenzepine treatment is ineffective in suppressing 24 ...
Large doses of pirenzepine given at bedtime suppress nocturnal GH secretion and abolish dawn phenomenon. As GH suppression may be beneficial in diabetic ...

Selectivity of pirenzepine in the central nervous system. III ...
Differential effects of multiple pirenzepine and scopolamine administrations on muscarinic receptors as measured autoradiographically. ...

The M1 muscarinic antagonist pirenzepine reduces myopia and eye ...
To determine the efficacy of the M1-selective muscarinic antagonist, pirenzepine , in preventing experimentally induced myopia in a mammalian model, ...